IDEXX Laboratories, Inc.

Informe acción NasdaqGS:IDXX

Capitalización de mercado: US$39.9b

Salud financiera de hoja de balance de IDEXX Laboratories

Salud financiera controles de criterios 6/6

IDEXX Laboratories tiene un patrimonio de accionistas total de $1.5B y una deuda total de $947.9M, lo que sitúa su ratio deuda-patrimonio en 63.9%. Sus activos y pasivos totales son $3.3B y $1.8B respectivamente. El BAIT de IDEXX Laboratories es de $1.1B, por lo que su ratio de cobertura de intereses es de 30.5. Tiene efectivo e inversiones a corto plazo que ascienden a $453.9M.

Información clave

60.3%

Ratio deuda-patrimonio

US$945.78m

Deuda

Ratio de cobertura de intereses41.8x
EfectivoUS$397.43m
PatrimonioUS$1.57b
Total pasivoUS$1.78b
Activos totalesUS$3.35b

Actualizaciones recientes sobre salud financiera

Recent updates

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 03
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

Apr 27
What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

Apr 11
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)

Apr 08

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jan 15
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

Dec 31
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Dec 15
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Oct 26
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 10
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Sep 07
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jul 04
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Apr 05
At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Feb 22
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Jan 05
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Nov 24
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Sep 20
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

Aug 15

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

Aug 15
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

IDEXX Laboratories Stock Is Very Expensive

Aug 08

IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M

Aug 02

Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Jul 26
Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Jul 12
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jun 16
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Great Business, But Still Overvalued

May 25

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

May 06
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

Apr 23
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Apr 09
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Mar 07
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories And Its Real Value

Feb 02

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Jan 06
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($1.5B) de IDXX superan a sus pasivos a corto plazo ($951.5M).

Pasivo a largo plazo: Los activos a corto plazo de IDXX ($1.5B) superan a sus pasivos a largo plazo ($823.8M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (33.3%) de IDXX se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de IDXX ha pasado de 2017.2% a 60.3% en los últimos 5 años.

Cobertura de la deuda: La deuda de IDXX está bien cubierta por el flujo de caja operativo (95.6%).

Cobertura de intereses: Los pagos de intereses de la deuda de IDXX están bien cubiertos por el BAIT (30.5x cobertura).


Hoja de balance


Descubre empresas con salud financiera